Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on May 19, 2025

2024 Ad Spending Benchmarks
VIRGINIA BEACH, VA, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- Schonfeld …

Nasscom GCC Summit 2025 Concludes Successfully, Spotlighting the Future of Global Capability Centers
Nasscom GCC Summit 2025 brought together 1,300+ leaders and 80+ speakers to explore the future of Global Capability Centers. HYDERABAD, TELENGANA, INDIA, May 19, 2025 /EINPresswire.com/ -- The 15th edition of the Nasscom GCC Summit 2025 held recently, …

Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
CARLSBAD, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC …

Intrinseque Health Wins Award For Best Clinical Supply Chain Solutions Provider 2025 – Singapore
Intrinseque Health wins Best Clinical Supply Chain Solutions Provider 2025 – Singapore, recognized for excellence in global clinical supply chain management. SINGAPORE, SINGAPORE, May 19, 2025 /EINPresswire.com/ -- Intrinseque Health adds another …

KabaFusion Acquires Infusion Care Assets from Coram® to Expand its Nationwide Footprint of Patient-Focused Services
LEXINGTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home and alternative site infusion, today announced it has closed on a transaction with Coram pursuant to which it has acquired 6 locations that will serve as …

Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WELLESLEY HILLS, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that the Company has granted an inducement …

Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference
Company’s first development candidate in autoimmune and inflammatory disease (AIID) demonstrates potent blockade of IL-4, IL-13, and IL-33 signaling pathways critical in respiratory inflammation Novel bispecific design shows promising potential …

Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025
LAKE FOREST, Ill., May 19, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the virtual Alliance Global Partners Healthcare Company …

Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions
Timothy Kieffer, Ph.D., appointed Chief Scientific Officer Danny Villeneuve appointed Chief Commercial Officer Terrie Kellmeyer, Ph.D., appointed Senior Vice President, Regulatory Affairs Christian Zapf, J.D., appointed General Counsel SAN DIEGO, May 19, …

Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting
First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barré Syndrome Outcomes Study (IGOS) Researchers Highlights Benefits over Current Standard of Care in Matched Patient Populations Poster Presentations on …

Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
- Interim Jan-2025 results from three trials of Alpha DaRT® in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R…

Collegium to Participate in Upcoming Investor Conferences
STOUGHTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Mizuho Neuro …

ELISpot and FluoroSpot Assay Market CAGR 16.73 % with Growth USD 1504.67 Billion by 2033
Global ELISpot and FluoroSpot Assay market size is predicted to reach 1504.67 million by 2033 from USD 436.5 million in 2025, registering a CAGR of 16.73%. PUNE, MAHARASHTRA, INDIA, May 19, 2025 /EINPresswire.com/ -- "ELISpot and FluoroSpot Assay Market …

Ramam Tech Releases Advanced RPA Solutions in the United States to Accelerate Healthcare Automation
WYOMING, WY, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- Responding to Rising Demand, the Business Fortifies Its Position as a Top RPA Development Company in the USA . Ramam Tech is now providing services in the United States, becoming an …

Bryan Post’s Trauma-Informed Parenting Tour Comes to Huntsville to Support Adoptive Families
HUNTSVILLE, AL, UNITED STATES, May 18, 2025 /EINPresswire.com/ -- On May 22, 2025, nationally recognized parenting and trauma expert Bryan Post will bring his From Fear to Love World Tour to Huntsville, Alabama, for a live, in-person workshop. Known for …

Sutter Health Awarded Proposition 1 Funding to Expand Behavioral Health Services Across Northern California
Northern California, May 19, 2025 (GLOBE NEWSWIRE) -- Building upon its commitment to expanding access to timely, high-quality mental health care, not-for-profit Sutter Health today announced it has been awarded $23 million through California’s Proposition …

Creative Diagnostics Provides High-quality ResDetFast™ Residual Nucleic Acid Extraction Kits for Research Applications
NEW YORK, NY, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- In the rapidly evolving field of molecular diagnostics, efficient and reliable nucleic acid extraction remains an important step for downstream applications. As an expert specializing in …

Life Sciences Analytics Market CAGR 7.23 % with Growth USD 39652.44 Billion by 2033
Life Sciences Analytics market size is anticipated to be worth USD 22685.04 M in 2025 and is expected to reach 39652.44 M by 2033 at a CAGR of 7.23%. PUNE, MAHARASHTRA, INDIA, May 19, 2025 /EINPresswire.com/ -- "Life Sciences Analytics Market" research …

Biopharma's New Power Couple: Creative Biolabs Debuts Functional mRNA Platform at 23rd BioPharma Conference
Creative Biolabs launches a trio of mRNA-centric innovations poised to slash drug development timelines at the 23rd BioPharma Conference (Booth #13, May 7–8). SHIRLEY, NY, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- The platform, designed to …

Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study
- For each 5-mg/dL increase in serum TTR level within 28 days of starting treatment, the relative risk reduction of mortality was up to 31.6% through Month 30, confirming the hypothesis that ever better levels of stabilization achieved by treatment with …